Friday, April 25, 2014 4:47 AM EST

Pfizer

Pfizer Incorporated (NYSE: PFE) is a pharmaceutical company, ranking number one in sales in the world. The company is based in New York City, with its research headquarters in Groton, Connecticut. It produces Lipitor (atorvastatin, used to lower blood cholesterol); the neuropathic pain/fibromyalgia drug Lyrica (pregabalin); the oral antifungal medication Diflucan (fluconazole), the antibiotic Zithromax (azithromycin), Viagra (sildenafil) for erectile dysfunction, and the anti-inflammatory Celebrex (celecoxib) (also known as Celebra in some countries outside the USA and Canada, mainly in South America).

Headlines Around the Web

Pfizer, Wyeth merge; entity in Top 10 club

Nov 24 - The Times of India

Pfizer, Wyeth boards approve merger in India

Nov 24 - The Times of India

Pfizer, Wyeth shares soar on merger talk

Nov 21 - The Times of India

Sun to pay $550m to Pfizer, Takeda

Jun 13 - The Times of India

Generic drug groups fined $2.15bn

Jun 13 - Financial Times

US groups criticise Indian protectionism

Mar 14, 2013 - Financial Times

Zoetis raises $2.24bn in IPO

Feb 01, 2013 - Financial Times

Articles About Pfizer

Asian shares rise as Fed Minutes Soothe Sentiment
Asian Stocks Flat after China PMI Meets Expectations

By Reuters

Asian stock markets were little moved on Wednesday after a Chinese manufacturing survey met expectations, but the Australian dollar plunged to a two-week low after data showed surprisingly low inflation in that country's economy. (Apr 23)

MORE TOPICS: CHINA, GOLD, HSBC, WESTPAC, MANUFACTURING, JAPAN

AstraZeneca
Global Markets Overview – 4/22/14

By IG Markets

There have been some very interesting corporate developments over the Easter break around corporate auctions. AstraZeneca, the UK's second largest pharmaceutical company, received a takeover bid from US giant Pfizer, Newmont Mining and Barrick G... (Apr 22)

MORE TOPICS: GOLD, TWITTER, FACEBOOK, JAPAN, AUSTRALIA, WOOLWORTHS

A Ranbaxy office building is pictured in the northern Indian city of Mohali on 14 May, 2013
Ranbaxy Shares Fall after U.S. Drug Recall

By Reuters

Shares in Ranbaxy Laboratories Ltd fell as much as 3.8 percent on Monday after the drug maker recalled more than 64,000 bottles of the generic version of a cholesterol-lowering drug in the United States after dosage mix-up was detected. (Mar 10)

Teva, Ranbaxy Settle Claims in U.S. Over Collusion
Teva, Ranbaxy Settle Claims in U.S. Over Collusion

By Reuters

The New York Attorney General and the U.S. units of Ranbaxy Laboratories(RANB.NS) and Teva Pharmaceutical Industries(TEVA.TA) have settled claims that an agreement between the two drugmakers unlawfully restricted competition. (Feb 19)

MORE TOPICS: NEW YORK, ATTORNEY GENERAL, ANTITRUST LAW, SETTLEMENT

A customer casts a close eye over the product in a Chinese pharmacy
Big Pharma Pushes for U.S. Action Against India on Drugs

By Reuters

Global pharmaceutical firms are pressuring the United States to act against India to stop more local companies producing up to a dozen new varieties of cheap generic drugs still on-patent, sources with direct knowledge of the matter said. (Feb 07)

MORE TOPICS: CHINA, WTO, PAKISTAN, ARGENTINA, THAILAND, RUSSIA

Wall Street
Wall Street Bounces Back as Bargain Hunters Move in

By Reuters

U.S. stocks rebounded on Tuesday, buoyed by encouraging earnings, as the market attempted to steady in the wake of its largest selloff in months a day earlier. (Feb 05)

MORE TOPICS: CHINA, DOW JONES, NYSE, MANAGEMENT, BIRD FLU

Boeing Announces $10 Billion Buyback, Raises Dividend

By Reuters

Boeing Co's (BA.N) board raised the company dividend about 50 percent on Monday and approved $10 billion in new share buyback authority that the company said it would use in the next two to three years. (Dec 17)

MORE TOPICS: MICROSOFT, GENERAL ELECTRIC, GOLDMAN SACHS, NEW YORK, INTEL

Indian Units of Pfizer and Wyeth to Merge

By Reuters

Pfizer Ltd(PFIZ.NS), the Indian unit of U.S. drug maker Pfizer Inc (PFE.N), is to take over local affiliate Wyeth Ltd (WLED.NS), they said on Saturday after their boards approved the deal. (Nov 24)

MORE TOPICS: CITIGROUP, BANK OF AMERICA, MERRILL LYNCH

China’s Bribery Culture Poses Massive Risks for Multinational Companies

By IBTimes UK

Officials in the United States and China probe numerous cases involving multinationals and bribery in China. (Nov 21)

MORE TOPICS: CHINA, SEC, JPMORGAN CHASE, SOUTH KOREA, NEW YORK, NIGERIA, IBM

Sun Pharma Raises 2013/14 Revenue Outlook to 25%

By Reuters

Sun Pharmaceutical Industries Ltd(SUN.NS), India's top drugmaker by market value, has raised its consolidated revenue growth outlook for the fiscal year ending March 2014 to 25 percent from 18 to 20 percent. (Nov 14)